Trial Profile
Effect of Secretin on Gastric Accommodation, Emptying and Post-nutrient Challenge Symptoms in Functional Dyspepsia and Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 15 Jun 2020
Price :
$35
*
At a glance
- Drugs Secretin (Primary)
- Indications Non-ulcer dyspepsia
- Focus Pharmacodynamics
- 12 Aug 2019 Status changed from recruiting to completed.
- 06 Dec 2018 Status changed from not yet recruiting to recruiting.
- 05 Nov 2018 Planned initiation date changed from 3 Sep 2018 to 7 Nov 2018.